Talks
New AGA MASLD Guidelines: In T2D Proceed Directly to Imaging
August 1, 2026
Share
Machine Learning Models for Diabetes Classification
August 1, 2026
Share
Diabetes Onset & Vascular Dementia
August 1, 2026
Share
Metabolic Surgery in Adolescents with T2D
August 1, 2026
Share
GLP1RA & Smell/Taste Changes
August 1, 2026
Share
T2D Extended Visits
August 1, 2026
Share
GLP1RA Impact in T2D/PAD
August 1, 2026
Share
CGM Use by PCPs & its Impact
August 1, 2026
Share
CV Risk Prediction in T2D/MASLD
August 1, 2026
Share
Mortality Differences in T2D/ESRD & CGM
August 1, 2026
Share
Acanthosis & Sirolimus
July 29, 2026
Share
Difficult to Control T2D & Hypercortisolism
July 29, 2026
Share
T2D & Hearing Loss
July 29, 2026
Share
Glycemia & Brain Health
July 29, 2026
Share
GLP1RA Implant
July 29, 2026
Share
GLP1RA & Hair Loss in T2D
July 29, 2026
Share
Reinitiation of GLP1RA in Patients with T2D
July 29, 2026
Share
Gastric Emptying & Response to Tirzepatide
July 29, 2026
Share
Retatrutide Filing to FDA in Early 2027
July 29, 2026
Share
GLP1RA & Fracture Risk in T2D
July 29, 2026
Share
ADA 2026: Lp(a) & T2D Relationship?
June 15, 2026
Share
ADA 2026: Berobenatide VESPER-2 Trial
June 15, 2026
Share
ADA 2026: Retatrutide TRANSCEND-T2D-1 Trial
June 15, 2026
Share
ADA 2026: CagriSema REIMAGINE-3 Results
June 15, 2026
Share
ADA 2026: CagriSema REIMAGINE-2 Results
June 15, 2026
Share
ADA 2026: CagriSema REIMAGINE-1 Study Results
June 15, 2026
Share
ADA 2026: Retatrutide TRIUMPH-1 Trial
June 15, 2026
Share
ADA 2026: Zenagamtide
June 15, 2026
Share
ADA 2026: Elecoglipron VISTA Obesity Trial
June 15, 2026
Share
ADA 2026: Elecoglipron SOLSTICE Trial
June 15, 2026
Share
ADA 2026: Amylin Symposium
May 24, 2026
Share
ADA 2026: Amylin Symposium
May 24, 2026
Share
GLP-1RA Gene Therapy for T2D
May 24, 2026
Share
GLP-1RA Gene Therapy for T2D
May 24, 2026
Share
Hidden CGM Patterns & AI-Powered Algorithms to Predict T2D
May 24, 2026
Share
Hidden CGM Patterns & AI-Powered Algorithms to Predict T2D
May 24, 2026
Share
Continued High Rate of Death Due to Diabetes & Metabolic Conditions
May 24, 2026
Share
Continued High Rate of Death Due to Diabetes & Metabolic Conditions
May 24, 2026
Share
Tandem's First Tubeless Device
May 24, 2026
Share
Tandem's First Tubeless Device
May 24, 2026
Share
Finerenone Benefits in T2D & CKD
May 24, 2026
Share
Finerenone Benefits in T2D & CKD
May 24, 2026
Share
GLP-1RA Bridge Program: Prediabetes
May 24, 2026
Share
GLP-1RA Bridge Program: Prediabetes
May 24, 2026
Share
GLP-1RA & Pancreatitis
May 24, 2026
Share
GLP-1RA & Pancreatitis
May 24, 2026
Share
GLP-1RAs + PPIs
May 24, 2026
Share
GLP-1RAs + PPIs
May 24, 2026
Share
Polyendocrine Metabolic Ovarian Syndrome
May 24, 2026
Share
Polyendocrine Metabolic Ovarian Syndrome
May 24, 2026
Share
ECO 2026: Orforglipron
May 24, 2026
Share
ECO 2026: Orforglipron
May 24, 2026
Share
Teplizumab Expanded Approval
April 27, 2026
Share
Teplizumab Expanded Approval
April 27, 2026
Share
Ketogenic Diet Impact on Beta-Cell Function
April 27, 2026
Share
Ketogenic Diet Impact on Beta-Cell Function
April 27, 2026
Share
PIONEER-TEENS Supports Efficacy & Safety of Oral Semaglutide in Children
April 27, 2026
Share
PIONEER-TEENS Supports Efficacy & Safety of Oral Semaglutide in Children
April 27, 2026
Share
Orforglipron (Foundayo) Cuts CV Risk & All-Cause Mortality
April 27, 2026
Share
Orforglipron (Foundayo) Cuts CV Risk & All-Cause Mortality
April 27, 2026
Share
Loading logo
Close button
Why are you reporting this TALK?